Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.63M | 1.63M | 1.48M | 1.48M | 1.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.63M | 1.63M | 1.48M | 1.48M | 1.69M |
| Cost of Revenue | 65.10K | 65.10K | 35.70K | 35.70K | 64.00K |
| Gross Profit | 1.57M | 1.57M | 1.44M | 1.44M | 1.62M |
| SG&A Expenses | 1.04M | 1.04M | 1.04M | 1.04M | 1.20M |
| Depreciation & Amortization | 53.80K | 53.80K | 78.00K | 78.00K | 100.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16M | 1.16M | 1.15M | 1.15M | 1.36M |
| Operating Income | 470.80K | 470.80K | 329.00K | 329.00K | 322.60K |
| Income Before Tax | 438.60K | 438.60K | 279.00K | 279.00K | 279.80K |
| Income Tax Expenses | 73.50K | 73.50K | 44.60K | 44.60K | 57.70K |
| Earnings from Continuing Operations | 365.10K | 365.10K | 234.40K | 234.40K | 222.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -20.30K |
| Net Income | 365.10K | 365.10K | 234.40K | 234.40K | 201.70K |
| EBIT | 470.80K | 470.80K | 329.00K | 329.00K | 322.60K |
| EBITDA | 524.60K | 524.60K | 406.90K | 406.90K | 423.50K |
| EPS Basic | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 15.34M | 15.34M | 15.34M | 15.34M | 15.34M |
| Average Diluted Shares Outstanding | 15.34M | 15.34M | 15.34M | 15.34M | 15.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |